Grow’s community newsletter all about the ecosystem of medical cannabis written by the team at Grow.
🙌 Welcome to this week’s Grow community newsletter.
🗣️ Our patient access lead Alex Fraser has been busy as always, and has written an insightful review of his participation in the Integro Medical Clinic’s event earlier in October.
Grow Pharma were delighted to co-sponsor and be invited to speak at the Royal Society of Medicine Medical Clinics educational event, hosted by Integro Medical Clinics.
The one-day event “Pain and Cannabis Medicines: Everything You Want to Know (but were afraid to ask)”, took place on Monday, 11th October and included an impressive agenda with presentations from eminent leading experts in their respective fields, primarily in medical cannabis prescribing, regulation, pharmacology and research.
I had the pleasure of kicking the day off with a presentation on the history of cannabis and route to legalisation on prescription in the UK.
We heard from the world-renowned Israeli biochemist Dr Raphael Mechoulam. Dr Mechoulam, now in his 90’s, discovered THC and the endocannabinoid system, making him a true legend in the field.
Dr Arno Hazekamp, an independent consultant with extensive experience in the field, including seven years as Dutch medical cannabis pioneer Bedrocan’s head of research. Also speaking was the insightful Paul Chrisp from NICE.
Integro Clinical Lead and Pain Specialist, Dr Anthony Ordman, gave an informative presentation on the uses of different formulations of cannabis medicines.
Integro Clinic Nurse, Sophie Hayes, delivered a comprehensive talk on the practicalities of caring for patients who are prescribed cannabis medicines.
Dr Basil Almahdi spoke about the potential of cannabis medicines in the treatment of migraines. Pain specialist Dr Sally Ghazaleh and Consultant Gynaecologist Srinivas Vindla gave insights on the use of cannabis medicines in the context of women’s health. Neuropsychiatrist Dr Mayur Bodani presented on mental health and cannabis medicines.
Oncologist Dr Andrew Gaya gave a powerful talk on the use of cannabis medicines for patients undergoing cancer treatment. He also gave an important review of the evidence to date for cannabinoids treating cancer and reducing tumour size (an area where prescriptions are not currently allowed and research is still in its infancy).
Dr Gaya presented a case study of a positive impact seen in one of his patients who had undergone six years of progressive cancer and various treatments. For those interested in learning more, there is an anonymised Instagram account covering the patient’s journey since being prescribed cannabis medicines.
A patient’s journey to accessing cannabis medicines can be a difficult and confusing one. At Grow, we strongly believe in making this as simple and efficient as possible.
Here’s a look at how patients currently streamline their process through Grow:
As part of Grow’s mission, we also educate and establish networks with doctors to assist both patients and healthcare practitioners to receive and give the best care possible. Take a peek at our Doctor’s Portal!
👀 Stay tuned for our next newsletter where Grow’s Co-Founder and CEO Ben Langley reflects on our history, successes, and how we’re moving forward in an always changing industry.
Tips to Grow 💪
🌱 Got anything to tell us? Drop us a note here!
🌱 Share this with your friends. Let’s get the word out about the great work we’re doing!